Obesity
Showing of 10 results
From GLP-1 to Triple Agonists: Transforming Cardiometabolic Care
Ian Neeland, MD, explains how incretin therapies are improving outcomes in cardiovascular, metabolic, and related conditions, while exploring mechanisms, muscle preservation, and strategies for long-term success.
Improving Risk Stratification for Critically Ill Patients with Obesity
Innovations in Pulmonology, Critical Care & Sleep Medicine | Summer 2025
Multidisciplinary Approaches to Obesity Management
Innovations in Diabetes & Metabolic Care | Summer 2025
Nutritional Counseling Is an Essential Pillar of Obesity Management
Innovations in Diabetes & Metabolic Care | Summer 2025
University Hospitals-led Study Highlights Potential Role for GLP-1RA in Secondary Prevention of AF
Innovations in Cardiovascular Medicine & Surgery | May 2025
Understanding and Changing Avoidance Behaviors Key to Care for Complex Patients, UH Pilot Project Shows
UH Clinical Update | November 2022
Results are loading...